Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Immunovant Inc (IMVT US)
Watchlist
15
Analysis
Health Care
•
United States
Immunovant Inc operates as a biopharmaceutical company. The Company offers discovers and manufactures drugs for patients with autoimmune diseases. Immunovant serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hanall Biopharma
•
14 Oct 2023 16:33
Hanall Biopharma (009420 KS): Pipeline Progress and New Deal Depict Brighter Outlook
China NMPA has accepted BLA filed by Hanall's partner for batoclimab to treat generalized myasthenia gravis. Hanall initiated phase 1 clinical...
Tina Banerjee
Follow
460 Views
Share
bullish
•
Hanall Biopharma
•
03 Oct 2022 14:58
Hanall Biopharma (009420 KS): Clinical Trial Progress of Key Pipeline Assets to Provide Some Upside
Hanall’s leading pipeline assets are progressing in late-stage trials through licensed global partners, thereby generating milestone payment...
Tina Banerjee
Follow
193 Views
Share
bullish
•
Immunovant Inc
•
25 May 2021 21:46
MergerTalk: Why Skepticism Over A Potential Immunovant Buyout May Offer A Lucrative Opportunity
Why we think it is more likely than not that minority shareholders of Immunovant (IMVT US) will receive a buyout proposal with a hefty premium...
Robert Sassoon
Follow
342 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x